HPSE and neoplasm: PG545 has also been reported to have immunomodulatory effects that are distinct from heparanase, and its stimulation of dendritic cells to produce IL-12 via a TLR9-dependent pathway which then activates NK cells, is now regarded as a key part of the anti-tumor effect of PG545 (100, 101).